发明申请
US20060040906A1 Piperazine urea derivatives as melanocortin-4 receptor agonists
失效
哌嗪脲衍生物作为黑皮质素-4受体激动剂
- 专利标题： Piperazine urea derivatives as melanocortin-4 receptor agonists
- 专利标题（中）： 哌嗪脲衍生物作为黑皮质素-4受体激动剂
-
申请号： US10526178申请日： 2003-09-05
-
公开(公告)号： US20060040906A1公开(公告)日： 2006-02-23
- 发明人: Raman Bakshi , Ravi Nargund , Brenda Palucki , Min Park , Zhixiong Ye
- 申请人： Raman Bakshi , Ravi Nargund , Brenda Palucki , Min Park , Zhixiong Ye
- 国际申请： PCT/US03/27892 WO 20030905
- 主分类号： A61K31/551
- IPC分类号： A61K31/551 ; A61K31/496 ; C07D403/02
摘要：
Certain novel piperazine urea derivatives are agonists of the human melanocortin-4 receptor (MC-4R) and, in particular, are receptor-subtype selective agonists of MC-4R. They are useful for the treatment, control, or prevention of diseases and disorders responsive to the activation of MC-4R, such as obesity and diabetes.
公开/授权文献
信息查询
